PPARA and systemic lupus erythematosus: Interestingly, GW0742, a highly potent and selective PPAR-β/δ agonist with 200-fold higher affinity toward PPAR-β/δ than other PPAR isotypes [16], prevented the reduced NO production induced by SLE plasma, confirming a direct effect on endothelial cells.